封面
市場調查報告書
商品編碼
1479938

甘露醇市場 - 2024 年至 2029 年預測

Mannitol Market - Forecasts from 2024 to 2029

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 139 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

甘露醇市場預計複合年成長率為 4.24%,從 2022 年的 517,442,000 美元市場規模到 2029 年達到 692,055,000 美元。

甘露醇是一種糖醇或糖醇,具有低溶解度和吸濕性,既可用作甜味劑,也可用作藥物。甘露醇天然存在於樹皮、新鮮菇類、褐藻、海藻以及大多數水果和蔬菜中。某些疾病的盛行率不斷上升、生活方式更加活躍以及所有地區的人口不斷成長預計將對市場產生積極影響。該產品在製藥工業中用作治療腎臟疾病、腦病和心臟病以及配製藥物的賦形劑。此外,它也用作壓片應用的填充劑。

消費者生活品質的顯著改善主要得益於個人收入的增加。隨著消費者健康意識的增強,人們的飲食習慣正在發生顯著變化。此外,公司正在投入更多的時間和資源來開發由天然成分製成的產品和專門為促進健康而設計的產品。因此,對低熱量天然甜味劑的需求不斷成長正在推動預測期內全球甘露醇市場的成長。糖尿病人口的成長也推動了擴張,因為甘露醇對消費者的血糖值幾乎沒有影響。

擴大甘露醇作為人造甜味劑的使用

市場擴張的一個主要因素是甘露醇作為食品添加劑和人工甜味劑的使用量不斷增加。甘露醇使血糖值遠低於蔗糖。因此,更多的產品被用於糖尿病飲食。此外,隨著肥胖和糖尿病的發病率增加,人們開始轉向更健康的食品,從而促進了市場的擴張。此外,由於甘露醇用於奶油、冷凍魚、已烹調義式麵食和嬰兒配方奶粉等產品,對甘露醇的需求也在增加。此外,隨著飲食習慣的改變和人們健康意識的增強,消費者越來越偏好低食品和零熱量食品,導致對人造甜味劑的需求增加。

食品和飲料行業的需求不斷成長

甘露醇在多種糖果零食製品中用作甜味劑,特別是砂糖產品。由於其溶解度低、潛熱高,甘露醇廣泛用於薄荷糖和泡泡糖的生產。甘露醇吸濕性極低,在濕度達到98%之前不會吸收空氣中的水分,非常適合用作硬糖、乾果、巧克力塗層、口香糖等的塗層。甘露醇優異的風味和質地使其成為咀嚼錠的首選賦形劑。

甘露醇的升糖指數比蔗糖低,是糖尿病患者的甜味劑。因此,肥胖、糖尿病、METABOLIC INC.症候群患者數量的增加以及消費者意識的提高正在導致甘露醇的積極擴張。

慢性病增加

甘露醇市場預計將主要受到導致糖尿病和其他心血管疾病的慢性病盛行率上升的推動。此外,糖尿病患者數量的增加以及適應各種無糖產品選擇的意願將推動甘露醇市場的發展。此外,根據世界衛生組織(WHO)稱,全球有4.22億人患有糖尿病,主要分佈在低收入和中等收入國家,該疾病每年直接導致160萬人死亡。

甘露醇的熱量比低熱量食品常見的碳水化合物少。甘露醇無需胰島素即可消化,因此適合糖尿病患者飲食。隨著糖尿病患者數量的增加,對低糖、低熱量產品的需求不斷增加。隨著人們越來越認知到食用低熱量砂糖有益於健康,預計未來幾年對甘露醇的需求將增加,並且市場預計在預測期內擴大。

製藥業的高需求

由於利尿劑、藥片錠劑以及心臟疾病、肺部和腎衰竭治療等用途的擴大,市場正在擴大。另外,由於其吸濕性低,具有清涼作用,已被用於口香糖、薄荷味糖果、咀嚼片等產品中,且市場不斷擴大。其他因素,例如該產品在烘焙和糖果零食中的採用增加、在壓片應用中作為填充劑的使用增加、持續的研發 (R&D) 活動以及持續的技術進步也有助於我們支持市場的積極前景。 。

亞太地區在預測期內將經歷指數級成長

預計亞太地區將佔據甘露醇的巨大市場佔有率。由於消費者健康意識的增強、都市化程度的提高和可支配收入的增加,預計該地區在預測期內將出現高速成長。甘露醇在中國和印度等新興市場的需求量大。由於飲食習慣的改變以及對低熱量產品和飲料的需求不斷增加,該地區的市場正在擴大。甘露醇不會影響血糖值,使其成為糖尿病患者的絕佳選擇。因此,印度和中國等國家糖尿病盛行率的上升正在推動這一領域的需求。

主要市場產品

  • 2022 年 11 月,領先的製藥和營養補充食品製造商羅蓋特 (Roquette) 宣布推出兩種用於直接壓片的下一代甘露醇解決方案:Pearitol CR-H 和 Pearlitol 200 GT。這兩種賦形劑都是專門為解決製藥行業獨特的配方挑戰而開發的,可幫助製造商最佳化直接壓片技術並實現控制釋放錠劑和微型片劑等創新,並正在擴展到各種應用領域。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現
  • 分析師觀點

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章甘露醇市場:依形式

  • 介紹
  • 粉末
  • 顆粒

第6章 甘露醇市場:依應用分類

  • 介紹
  • 食品
  • 藥品
  • 產業
  • 其他

第7章甘露醇市場:依地區

  • 介紹
  • 北美洲
    • 按形式
    • 按用途
    • 按國家/地區
  • 南美洲
    • 按形式
    • 按用途
    • 按國家/地區
  • 歐洲
    • 按形式
    • 按用途
    • 按國家/地區
  • 中東/非洲
    • 按形式
    • 按用途
    • 按國家/地區
  • 亞太地區
    • 按形式
    • 按用途
    • 按國家/地區

第8章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第9章 公司簡介

  • Roquette Freres Company
  • Cargill, Incorporated.
  • Ingredion Incorporated
  • SPI Pharm
  • Singsino Group Ltd.,
  • Merck Millipore Corporation
  • Bright Moon Seaweed
簡介目錄
Product Code: KSI061615253

The mannitol market is expected to grow at a CAGR of 4.24% reaching a market size of US$692.055 million in 2029 from US$517.442 million in 2022.

Mannitol is a type of sugar polyol or sugar alcohol with low solubility and hygroscopicity and is used as both a sweetener and a drug. Mannitol is naturally found in tree bark, fresh mushrooms, brown algae, seaweed, and most fruits and vegetables. Increased prevalence of certain diseases, a more dynamic lifestyle, and growing populations in all regions are expected to have a positive effect on the market. This product is used as an excipient in the pharmaceutical industry to treat kidney, brain, and heart diseases as well as to formulate pharmaceutical products. Additionally, it is employed in tableting applications as a bulking agent.

The consumer's quality of life has greatly improved, owing mostly to increased personal income. As a result of rising health consciousness among consumers, the population's eating habits have shifted substantially. Furthermore, firms are investing a lot of time and resources in developing products composed of natural ingredients and specialized goods that improve health. As a result, rising demand for low-calorie natural sweeteners is propelling the growth of the global market for mannitol throughout the projected period. The growing diabetic population is also driving expansion since mannitol has little to no effect on the consumer's blood sugar level.

Increasing application of mannitol as an artificial sweetener

The main driver of the market expansion is the growing use of mannitol as a food additive and artificial sweetener. Mannitol causes a much smaller rise in blood sugar when compared to sucrose. Consequently, more products are being used in diabetic food. In addition, there has been a noticeable shift toward healthier food options as a result of the growing rates of obesity and diabetes, which is helping the market expand. In addition, the demand for the product has increased due to the increasing use of mannitol in butter, frozen fish, pre-cooked pasta, and baby formula. Furthermore, as dietary habits change and health consciousness rises, consumers' preferences for low- and zero-calorie foods are growing, which has increased the demand for artificial sweeteners.

Increasing demand in food & beverages industry

Mannitol is used as a sweetener in various confectionary goods, especially sugar-free products. Due to low solubility and high latent heat, mannitol is extensively used to produce mint candies and bubble gums. It has a very low hygroscopicity, meaning that it does not absorb water from the air until the humidity level reaches 98 percent, which makes it an excellent covering for hard candies, dried fruits, chocolate coatings, and chewing gums. Mannitol's excellent flavour and texture make it a preferred excipient for chewable tablets.

Mannitol has a lower glycemic index than sucrose and is a sweetener for diabetic patients. Therefore, an increasing number of cases of obesity, diabetes, and metabolic syndrome, along with improved consumer awareness, has resulted in a positive expansion of mannitol.

Increasing cases of chronic diseases

The market for mannitol is expected to be driven primarily by the rising prevalence of chronic diseases, which can lead to diabetes and other cardiovascular diseases. Furthermore, the growing number of diabetes patients and their willingness to adjust to various sugar-free product options will drive the market for mannitol. Furthermore, 422 million people worldwide, mostly in low- and middle-income nations, have diabetes, according to the World Health Organization, and the disease is directly responsible for 1.6 million deaths annually.

Compared to carbohydrates, which are frequently used in low-calorie foods, mannitol has fewer calories. Mannitol is a good option for diabetic diets because it can be digested without the need for insulin. The demand for low-sugar and low-calorie products is rising in tandem with the rise in the number of patients with diabetes. People's awareness of the health benefits of consuming low-calorie sugar is expected to increase demand for mannitol in the upcoming years, and the market is expected to grow during the forecast period.

High demand from the pharmaceutical industry

The market has grown as a result of the expanding uses of the product, which include diuretics, excipients in pharmaceutical tablets, and the treatment of heart and lung conditions as well as renal failure. Accordingly, the market has grown as a result of the increasing use of mannitol in chewing gum, mint-flavored candies, and chewable tablets due to its low hygroscopicity and cooling effect. A positive market outlook is also being fueled by other factors, such as growing product adoption in bakery and confectionery items, growing use as a bulking agent for tableting applications, continuing research and development (R&D) activities, and ongoing technological advancements.

Asia Pacific is witnessing exponential growth during the forecast period

Asia Pacific region is anticipated to hold a significant market share in mannitol. This region will witness high growth during the forecast period due to the rising health copiousness among consumers, increased urbanization, and rising disposable income. Mannitol is in high demand in rising markets such as China and India. This region's market is expanding due to changing eating habits and rising demand for low-calorie products and drinks. Mannitol does not affect blood sugar levels, making them an excellent choice for diabetic individuals. As a result, increased diabetes incidence in countries such as India and China is driving demand in this area

Market key launches

  • In November 2022, Roquette, a major pharmaceutical and nutraceutical excipients manufacturer, introduced two next-generation mannitol solutions for direct compression: Pearlitol CR-H and Pearlitol 200 GT. Both excipients were created specifically to address unique drug formulation issues in the pharmaceutical industry, assisting manufacturers in optimizing direct compression techniques and expanding into innovative application areas such as controlled-release tablets and tiny tabs.

Segmentation:

By Form

  • Powder
  • Granules

By Application

  • Food
  • Pharmaceuticals
  • Industrial
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. MANNITOL MARKET, BY FORM

  • 5.1. Introduction
  • 5.2. Powder
    • 5.2.1. Market Trends and Opportunities
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Granules
    • 5.3.1. Market Trends and Opportunities
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness

6. MANNITOL MARKET, BY APPLICATION

  • 6.1. Introduction
  • 6.2. Food
    • 6.2.1. Market Trends and Opportunities
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Pharmaceuticals
    • 6.3.1. Market Trends and Opportunities
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Industrial
    • 6.4.1. Market Trends and Opportunities
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. Others
    • 6.5.1. Market Trends and Opportunities
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness

7. MANNITOL MARKET, BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. By Form
    • 7.2.2. By Application
    • 7.2.3. By Country
      • 7.2.3.1. United States
        • 7.2.3.1.1. Market Trends and Opportunities
        • 7.2.3.1.2. Growth Prospects
      • 7.2.3.2. Canada
        • 7.2.3.2.1. Market Trends and Opportunities
        • 7.2.3.2.2. Growth Prospects
      • 7.2.3.3. Mexico
        • 7.2.3.3.1. Market Trends and Opportunities
        • 7.2.3.3.2. Growth Prospects
  • 7.3. South America
    • 7.3.1. By Form
    • 7.3.2. By Application
    • 7.3.3. By Country
      • 7.3.3.1. Brazil
        • 7.3.3.1.1. Market Trends and Opportunities
        • 7.3.3.1.2. Growth Prospects
      • 7.3.3.2. Argentina
        • 7.3.3.2.1. Market Trends and Opportunities
        • 7.3.3.2.2. Growth Prospects
      • 7.3.3.3. Others
        • 7.3.3.3.1. Market Trends and Opportunities
        • 7.3.3.3.2. Growth Prospects
  • 7.4. Europe
    • 7.4.1. By Form
    • 7.4.2. By Application
    • 7.4.3. By Country
      • 7.4.3.1. United Kingdom
        • 7.4.3.1.1. Market Trends and Opportunities
        • 7.4.3.1.2. Growth Prospects
      • 7.4.3.2. Germany
        • 7.4.3.2.1. Market Trends and Opportunities
        • 7.4.3.2.2. Growth Prospects
      • 7.4.3.3. France
        • 7.4.3.3.1. Market Trends and Opportunities
        • 7.4.3.3.2. Growth Prospects
      • 7.4.3.4. Spain
        • 7.4.3.4.1. Market Trends and Opportunities
        • 7.4.3.4.2. Growth Prospects
      • 7.4.3.5. Others
        • 7.4.3.5.1. Market Trends and Opportunities
        • 7.4.3.5.2. Growth Prospects
  • 7.5. Middle East and Africa
    • 7.5.1. By Form
    • 7.5.2. By Application
    • 7.5.3. By Country
      • 7.5.3.1. Saudi Arabia
        • 7.5.3.1.1. Market Trends and Opportunities
        • 7.5.3.1.2. Growth Prospects
      • 7.5.3.2. UAE
        • 7.5.3.2.1. Market Trends and Opportunities
        • 7.5.3.2.2. Growth Prospects
      • 7.5.3.3. Israel
        • 7.5.3.3.1. Market Trends and Opportunities
        • 7.5.3.3.2. Growth Prospects
      • 7.5.3.4. Others
        • 7.5.3.4.1. Market Trends and Opportunities
        • 7.5.3.4.2. Growth Prospects
  • 7.6. Asia Pacific
    • 7.6.1. By Form
    • 7.6.2. By Application
    • 7.6.3. By Country
      • 7.6.3.1. Japan
        • 7.6.3.1.1. Market Trends and Opportunities
        • 7.6.3.1.2. Growth Prospects
      • 7.6.3.2. China
        • 7.6.3.2.1. Market Trends and Opportunities
        • 7.6.3.2.2. Growth Prospects
      • 7.6.3.3. India
        • 7.6.3.3.1. Market Trends and Opportunities
        • 7.6.3.3.2. Growth Prospects
      • 7.6.3.4. South Korea
        • 7.6.3.4.1. Market Trends and Opportunities
        • 7.6.3.4.2. Growth Prospects
      • 7.6.3.5. Indonesia
        • 7.6.3.5.1. Market Trends and Opportunities
        • 7.6.3.5.2. Growth Prospects
      • 7.6.3.6. Thailand
        • 7.6.3.6.1. Market Trends and Opportunities
        • 7.6.3.6.2. Growth Prospects
      • 7.6.3.7. Others
        • 7.6.3.7.1. Market Trends and Opportunities
        • 7.6.3.7.2. Growth Prospects

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Roquette Freres Company
  • 9.2. Cargill, Incorporated.
  • 9.3. Ingredion Incorporated
  • 9.4. SPI Pharm
  • 9.5. Singsino Group Ltd.,
  • 9.6. Merck Millipore Corporation
  • 9.7. Bright Moon Seaweed